Coronary heart disease is associated with non-amnestic mild cognitive impairment

Rosebud O Roberts1, David S Knopman, Yonas E Geda

  • 1Mayo Clinic, Department of Health Sciences Research, Division of Epidemiology, 200 First Street SW, Rochester, MN 55905, United States. roberts.rosebud@mayo.edu

Neurobiology of Aging
|December 19, 2008
PubMed

Insights

Coronary heart disease (CHD) is linked to non-amnestic mild cognitive impairment (na-MCI), but not amnestic mild cognitive impairment (a-MCI). This suggests shared causes between CHD and na-MCI, distinct from a-MCI pathways.

Area of Science:

  • Gerontology
  • Cardiology
  • Neurology

Background:

  • Mild cognitive impairment (MCI) has subtypes, amnestic (a-MCI) and non-amnestic (na-MCI).
  • a-MCI often progresses to Alzheimer's disease, while na-MCI may link to vascular or non-degenerative dementias.
  • Understanding subtype-specific etiologies is crucial for targeted interventions.

Purpose of the Study:

  • To investigate the association between coronary heart disease (CHD) and distinct subtypes of mild cognitive impairment (MCI).
  • To explore potential shared etiologies between cardiovascular health and cognitive decline subtypes.

Main Methods:

  • A population-based cohort of 1969 participants aged 70-89 years was studied.
  • Diagnoses of normal cognition, MCI (a-MCI and na-MCI), or dementia were established using clinical and neuropsychological assessments.
  • Coronary heart disease (CHD) was identified through medical history, interviews, and records, defined by myocardial infarction, angina, stenosis, or revascularization.

Main Results:

  • Coronary heart disease (CHD) showed a significant association with non-amnestic MCI (na-MCI) (OR=1.93).
  • No significant association was found between CHD and amnestic MCI (a-MCI) (OR=0.94).
  • The ApoE ɛ4 allele was associated with a-MCI (OR=1.75) but not na-MCI (OR=1.17).

Conclusions:

  • The findings suggest that coronary heart disease (CHD) is specifically associated with prevalent non-amnestic mild cognitive impairment (na-MCI).
  • This association implies shared underlying pathophysiological mechanisms between CHD and na-MCI.
  • The distinct associations highlight different etiological pathways for a-MCI and na-MCI.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.